These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 7994033)

  • 21. Gene cloning of rat and mouse platelet glycoprotein V: identification of megakaryocyte-specific promoters and demonstration of functional thrombin cleavage.
    Ravanat C; Morales M; Azorsa DO; Moog S; Schuhler S; Grunert P; Loew D; Van Dorsselaer A; Cazenave JP; Lanza F
    Blood; 1997 May; 89(9):3253-62. PubMed ID: 9129030
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Thrombin receptor-activating peptides (TRAPs): investigation of bioactive conformations via structure-activity, spectroscopic, and computational studies.
    Ceruso MA; McComsey DF; Leo GC; Andrade-Gordon P; Addo MF; Scarborough RM; Oksenberg D; Maryanoff BE
    Bioorg Med Chem; 1999 Nov; 7(11):2353-71. PubMed ID: 10632045
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Synthesis of novel peptide inhibitors of thrombin-induced platelet activation.
    Burke FM; Warnock M; Schmaier AH; Mosberg HI
    Chem Biol Drug Des; 2006 Nov; 68(5):235-8. PubMed ID: 17177882
    [TBL] [Abstract][Full Text] [Related]  

  • 24. alpha-Thrombin-induced human platelet activation results solely from formation of a specific enzyme-substrate complex.
    Hayes KL; Leong L; Henriksen RA; Bouchard BA; Ouellette L; Church WR; Tracy PB
    J Biol Chem; 1994 Nov; 269(46):28606-12. PubMed ID: 7961808
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Thrombin receptor activating mutations. Alteration of an extracellular agonist recognition domain causes constitutive signaling.
    Nanevicz T; Wang L; Chen M; Ishii M; Coughlin SR
    J Biol Chem; 1996 Jan; 271(2):702-6. PubMed ID: 8557676
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Plasmin desensitization of the PAR1 thrombin receptor: kinetics, sites of truncation, and implications for thrombolytic therapy.
    Kuliopulos A; Covic L; Seeley SK; Sheridan PJ; Helin J; Costello CE
    Biochemistry; 1999 Apr; 38(14):4572-85. PubMed ID: 10194379
    [TBL] [Abstract][Full Text] [Related]  

  • 27. An immunodominant epitope in a functional domain near the N-terminus of human granulocyte-macrophage colony-stimulating factor identified by cross-reaction of synthetic peptides with neutralizing anti-protein and anti-peptide antibodies.
    Beffy P; Rovero P; Di Bartolo V; Laricchia Robbio L; Dané A; Pegoraro S; Bertolero F; Revoltella RP
    Hybridoma; 1994 Dec; 13(6):457-68. PubMed ID: 7737670
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Mapping of a B-cell epitope present in the neuraminidase of Trypanosoma cruzi.
    Prioli RP; Ortega-Barria E; Mejia JS; Pereira ME
    Mol Biochem Parasitol; 1992 May; 52(1):85-96. PubMed ID: 1378212
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Thrombin interaction with platelet membrane glycoprotein Ib.
    Jandrot-Perrus M; Bouton MC; Lanza F; Guillin MC
    Semin Thromb Hemost; 1996; 22(2):151-6. PubMed ID: 8807712
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Crystallographic structures of thrombin complexed with thrombin receptor peptides: existence of expected and novel binding modes.
    Mathews II; Padmanabhan KP; Ganesh V; Tulinsky A; Ishii M; Chen J; Turck CW; Coughlin SR; Fenton JW
    Biochemistry; 1994 Mar; 33(11):3266-79. PubMed ID: 8136362
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Structure and function of the human platelet thrombin receptor. Studies using monoclonal antibodies directed against a defined domain within the receptor N terminus.
    Brass LF; Vassallo RR; Belmonte E; Ahuja M; Cichowski K; Hoxie JA
    J Biol Chem; 1992 Jul; 267(20):13795-8. PubMed ID: 1321125
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Proteolysis of the exodomain of recombinant protease-activated receptors: prediction of receptor activation or inactivation by MALDI mass spectrometry.
    Loew D; Perrault C; Morales M; Moog S; Ravanat C; Schuhler S; Arcone R; Pietropaolo C; Cazenave JP; van Dorsselaer A; Lanza F
    Biochemistry; 2000 Sep; 39(35):10812-22. PubMed ID: 10978167
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Protease-activated receptor-1 can mediate responses to SFLLRN in thrombin-desensitized cells: evidence for a novel mechanism for preventing or terminating signaling by PAR1's tethered ligand.
    Hammes SR; Coughlin SR
    Biochemistry; 1999 Feb; 38(8):2486-93. PubMed ID: 10029543
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Domains specifying thrombin-receptor interaction.
    Vu TK; Wheaton VI; Hung DT; Charo I; Coughlin SR
    Nature; 1991 Oct; 353(6345):674-7. PubMed ID: 1717851
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Thrombin interaction with a recombinant N-terminal extracellular domain of the thrombin receptor in an acellular system.
    Bouton MC; Jandrot-Perrus M; Moog S; Cazenave JP; Guillin MC; Lanza F
    Biochem J; 1995 Jan; 305 ( Pt 2)(Pt 2):635-41. PubMed ID: 7832783
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Thrombin affinity mapping of its receptor tethered ligand.
    Witting JI; Brezniak DV; Andersen TT; Fenton JW
    Blood Coagul Fibrinolysis; 1997 Jan; 8(1):65-9. PubMed ID: 9105640
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Thrombin receptor activation by thrombin and receptor-derived peptides in platelet and CHRF-288 cell membranes: receptor-stimulated GTPase and evaluation of agonists and partial agonists.
    Seiler SM; Peluso M; Tuttle JG; Pryor K; Klimas C; Matsueda GR; Bernatowicz MS
    Mol Pharmacol; 1996 Jan; 49(1):190-7. PubMed ID: 8569706
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Localization and characterization of an alpha-thrombin-binding site on platelet glycoprotein Ib alpha.
    De Marco L; Mazzucato M; Masotti A; Ruggeri ZM
    J Biol Chem; 1994 Mar; 269(9):6478-84. PubMed ID: 8119999
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Constitutive transactivation by the thyroid hormone receptor and a novel pattern of activity of its oncogenic homolog v-ErbA in Xenopus oocytes.
    Nagl SB; Nelson CC; Romaniuk PJ; Allison LA
    Mol Endocrinol; 1995 Nov; 9(11):1522-32. PubMed ID: 8584030
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The N-terminal thrombin receptor fragment SFLLRN, but not catalytically inactive thrombin-derived agonists, activate U937 human monocytic cells: evidence for receptor hydrolysis in thrombin-dependent signalling.
    Joseph S; MacDermot J
    Biochem J; 1993 Mar; 290 ( Pt 2)(Pt 2):571-7. PubMed ID: 8383967
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.